Webster
WEBSTER, Texas, December 15, 2011 -
IDEV Technologies, Inc.
WEBSTER, Texas, November 10, 2011 -
Lower Profile Provides Easier Operation, Improved Delivery Control and Efficiencies
IDEV Technologies, Incorporated (IDEV), today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
WEBSTER, Texas, July 12, 2011 -
- Improved Operation and Control Make Stent Delivery More
Efficient and Predictable
IDEV Technologies, Incorporated (IDEV), today announced the
first procedures in Europe utilizing the new 6 French (6Fr) SUPERA
VERITAS Peripheral Vascular System.
WEBSTER, Texas, June 2, 2011 -
- IDE Study Examines Performance of SUPERA(R) Stent in Superficial
Femoral Artery (SFA)
IDEV Technologies, Inc.
WEBSTER, Texas, April 14, 2011 - The Medical Devices Bureau of Health Canada has granted regulatory
approval for the SUPERA VERITAS stent system for use in biliary and
peripheral procedures.
More News
- Commercial Launch of Stent Delivery System Planned for Early 2011
- New SUPERA(R) Delivery System Improves Procedure Predictability and Stent Performance
- New Sizes of SUPERA(R) Stent Expand Treatment Options for Peripheral Vascular Disease
- Proceeds to Fund Clinical Trials, New Product Development, Continued Revenue Growth
- Company Expands Product Portfolio
- Provides Significant and Broad Expertise in Clinical Trials, Regulatory Affairs
- Innovative Technology Provides Precision, Ease of Use For Delivery of SUPERA(R) Stent
